+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Hypermethylation of WIF1 and its inhibitory role in the tumor growth of endometrial adenocarcinoma

Hypermethylation of WIF1 and its inhibitory role in the tumor growth of endometrial adenocarcinoma

Molecular Medicine Reports 16(5): 7497-7503

Endometrial carcinoma is the most common malignancy of the female genital tract and is the fourth most common malignancy among women worldwide. Endometrial adenocarcinoma (EAC) accounts for ~80% of endometrial carcinoma cases. Numerous critical genetic events have been determined to serve an essential role in EAC progression; however, the precise molecular mechanisms underlying EAC progression remain unclear. Pyrosequencing and methylation‑specific PCR were used to detect the methylation status of Wnt inhibitory factor 1 (WIF1). Immunohistochemistry and western blot were used to detect the expression of WIF1, Wnt family member 1 and other related pathways. The anticancer role of WIF1 in EAC was investigated in vitro and in vivo. Two of the three EAC cases exhibited significantly high methylation in five CpG sites, and the WIF1 methylation rate in EAC and endometrial tissues was 43.4 and 8%, respectively (P<0.05). The kappa consistency coefficient was ‑0.369 between methylation and mRNA expression (P<0.05) and WIF1 expression levels were significantly downregulated in EAC tissues compared with non‑tumorous tissues (P<0.01). The 5‑year overall survival rates were significantly lower for patients with tumors that negatively expressed WIF1 when compared with the 77.9% exhibited by those with positive WIF1 expression. Furthermore, the proliferation rate of KLE cells was significantly reduced following 5‑aza‑20‑deoxycytidine treatment or WIF1 overexpression in vitro and in vivo, which may be associated with downregulated c‑Myc and phosphorylated‑extracellular signal‑regulated kinase expression. These results demonstrated the important role of WIF1 in EAC tumorigenesis, and suggested that WIF1 may be a potential drug target in EAC treatment.

(PDF emailed within 0-6 h: $19.90)

Accession: 059818190

Download citation: RISBibTeXText

PMID: 28944908

DOI: 10.3892/mmr.2017.7564

Related references

Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer. Molecular Carcinogenesis 52(6): 475-487, 2013

Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma. International Journal of Cancer 118(9): 2168-2171, 2005

The Wnt inhibitory factor 1 (WIF1) is targeted in glioblastoma and has a tumor suppressing function potentially by induction of senescence. Neuro-Oncology 13(7): 736-747, 2011

G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines. Steroids 78(11): 1087-1091, 2014

Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells. Oncology Reports 11(4): 875-879, 2004

A novel case of endometrial dedifferentiated adenocarcinoma associated with MLH1 promotor hypermethylation and microsatellite instability. Pathology, Research and Practice 214(11): 1904-1908, 2018

The role of glypicans in Wnt inhibitory factor-1 activity and the structural basis of Wif1's effects on Wnt and Hedgehog signaling. Plos Genetics 8(2): E1002503, 2013

Role of tumor-associated glycoprotein-72 in the progression of endometrial adenocarcinoma: a proposed study. Medical Hypotheses 84(5): 413-416, 2015

Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review. Oncotarget 8(2): 2550-2557, 2016

Growth interaction between different tumor populations in human endometrial adenocarcinoma growing in nude mice. In Vivo 7(6a): 511-517, 1993

Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers. Oral Diseases 17(8): 794-800, 2012

Wif1 hypermethylation as unfavorable prognosis of non-small cell lung cancers with EGFR mutation. Molecules and Cells 36(1): 69-73, 2014

Hypermethylation of RUNX3 but not WIF1 gene association with stage and nodal status of tongue cancers. 2011

Inhibitory effect of tumor suppressor PTEN on cell growth of endometrial carcinoma. Zhonghua Zhong Liu Za Zhi 26(5): 275-278, 2004

MiR-106a promotes tumor growth, migration, and invasion by targeting BCL2L11 in human endometrial adenocarcinoma. American Journal of Translational Research 9(11): 4984-4993, 2017